hepatitis C
‘Impossible to predict’ how demand will unfold
Uncertainty thanks to the COVID-19 pandemic means Sigma won’t give full guidance as to earnings, but the wholesaler has achieved “outstanding” results, it says In a statement to the ASX …
Top 10 most common, most costly drugs
Drugs to treat Hepatitis C have cost the taxpayer more than $1 billion in 2018, and have topped the list of drugs ranked by cost to government in 2017-18 NPS …
Australia’s 10 most expensive drugs
Expensive medicines used to treat hepatitis C have cost the government more than any other drugs over the past year New figures based on PBS and RPBS scripts for the …
The week in review
For the most part, it’s been a positive week in Australian pharmacy The Pharmaceutical Society’s conference, PSA17, has seen a number of positive announcements made: Health Minister Greg Hunt declared …
New once-daily Hep C treatment recommended for PBS
The first and only one-tablet, once-a-day treatment for all genotypes of chronic hepatitis C infection has been recommended for PBS listing Gilead Sciences Australia has announced that the TGA has …